TOPICA Pharmaceuticals' Series B Round

TOPICA Pharmaceuticals raised a round of funding on October 18, 2011.

TOPICA Pharmaceuticals is a privately held clinical research stage pharmaceutical company focused on developing luliconazole for the treatment of onychomycosis, fungal infections of the nail. The comp…

Articles about TOPICA Pharmaceuticals' Series B Round: